Key facts for NCD 160.12
- Benefit category
- No Benefit Category
- Effective date
- 10/01/2006
- Implemented 10/02/2006
- Transmittal
- Transmittal 55
- Versions published
- 2
TL;DR
NCD 160.12 sets Medicare's national policy for neuromuscular electrical stimulation (nmes) under the benefit category "No Benefit Category", effective 10/01/2006 and implemented 10/02/2006. Coverage of NMES to treat muscle atrophy is limited to the treatment of disuse atrophy where nerve supply to the muscle is intact, including brain, spinal cord and peripheral nerves, and other non-neurological reasons for disuse atrophy. Some examples would… It has been revised 1 time since publication and binds every Medicare Administrative Contractor nationally.
Item or service described
NMES involves the use of a device which transmits an electrical impulse to the skin over selected muscle groups by way of electrodes. There are two broad categories of NMES. One type of device stimulates the muscle when the patient is in a resting state to treat muscle atrophy. The second type is used to enhance functional activity of neurologically impaired patients.
Indications and limitations of coverage
Treatment of Muscle Atrophy
Coverage of NMES to treat muscle atrophy is limited to the treatment of disuse atrophy where nerve supply to the muscle is intact, including brain, spinal cord and peripheral nerves, and other non-neurological reasons for disuse atrophy. Some examples would be casting or splinting of a limb, contracture due to scarring of soft tissue as in burn lesions, and hip replacement surgery (until orthotic training begins). (See § 160.13 of the NCD Manual for an explanation of coverage of medically necessary supplies for the effective use of NMES.)
Use for Walking in Patients with Spinal Cord Injury (SCI)
The type of NMES that is use to enhance the ability to walk of SCI patients is commonly referred to as functional electrical stimulation (FES). These devices are surface units that use electrical impulses to activate paralyzed or weak muscles in precise sequence. Coverage for the use of NMES/FES is limited to SCI patients for walking, who have completed a training program which consists of at least 32 physical therapy sessions with the device over a period of three months. The trial period of physical therapy will enable the physician treating the patient for his or her spinal cord injury to properly evaluate the person's ability to use these devices frequently and for the long term. Physical therapy necessary to perform this training must be directly performed by the physical therapist as part of a one-on-one training program.
The goal of physical therapy must be to train SCI patients on the use of NMES/FES devices to achieve walking, not to reverse or retard muscle atrophy.
Coverage for NMES/FES for walking will be covered in SCI patients with all of the following characteristics:
• Persons with intact lower motor units (L1 and below) (both muscle and peripheral nerve);
• Persons with muscle and joint stability for weight bearing at upper and lower extremities that can demonstrate balance and control to maintain an upright support posture independently;
• Persons that demonstrate brisk muscle contraction to NMES and have sensory perception electrical stimulation sufficient for muscle contraction;
• Persons that possess high motivation, commitment and cognitive ability to use such devices for walking;
• Persons that can transfer independently and can demonstrate independent standing tolerance for at least 3 minutes;
• Persons that can demonstrate hand and finger function to manipulate controls;
• Persons with at least 6-month post recovery spinal cord injury and restorative surgery;
• Persons without hip and knee degenerative disease and no history of long bone fracture secondary to osteoporosis; and
• Persons who have demonstrated a willingness to use the device long-term.
NMES/FES for walking will not be covered in SCI patient with any of the following:
• Persons with cardiac pacemakers;
• Severe scoliosis or severe osteoporosis;
• Skin disease or cancer at area of stimulation;
• Irreversible contracture; or
• Autonomic dysflexia.
The only settings where therapists with the sufficient skills to provide these services are employed, are inpatient hospitals; outpatient hospitals; comprehensive outpatient rehabilitation facilities; and outpatient rehabilitation facilities. The physical therapy necessary to perform this training must be part of a one-on-one training program.
Additional therapy after the purchase of the DME would be limited by our general policies in converge of skilled physical therapy.
Text reproduced from the CMS Medicare Coverage Database record for NCD 160.12 version 2. View the original on cms.gov.
Local policies that build on this NCD
5 active Local Coverage Determinations cite NCD 160.12 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.
- LCD L33631: Outpatient Physical and Occupational Therapy Services · Wellpoint Federal
- Outpatient Occupational Therapy, LCD L34427 · Palmetto GBA
- Outpatient Physical Therapy (L34428) · Palmetto GBA
- LCD L34560: Home Health Occupational Therapy · Palmetto GBA
- Home Health Physical Therapy, LCD L34564 · Palmetto GBA
How MACs bill NCD 160.12
A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 2 current articles in the Medicare Coverage Database name NCD 160.12, 2 of them with a covered ICD-10-CM list, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.
| Contractor | Articles |
|---|---|
| Palmetto GBA | A53065 |
| Wellpoint Federal | A56566 |
A53065: Billing and Coding: Outpatient Physical Therapy
Billing and Coding, effective 2026-10-01 · Palmetto GBA (10111, 10211, 10311, 11201, 11301, 11401, 11501) · CMS record
22,208 covered ICD-10-CM codes; 80 procedure codes: 29065, 29075, 29085, 29105, 29125, 29126, 29130, 29131, 29200, 29240, 29260, 29280 and 68 more. Local policy: L34428 Outpatient Physical Therapy. Check a diagnosis for 29065.
First covered codes: A18.01 Tuberculosis of spine; B91 Sequelae of poliomyelitis; E08.40 Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified; E08.42 Diabetes mellitus due to underlying condition with diabetic polyneuropathy; E08.44 Diabetes mellitus due to underlying condition with diabetic amyotrophy; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; …
A56566: Billing and Coding: Outpatient Physical and Occupational Therapy Services
Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record
3 covered ICD-10-CM codes, 1,300 non-covered; 90 procedure codes: 0552T, 29065, 29075, 29085, 29086, 29105, 29125, 29126, 29130, 29131, 29200, 29240 and 78 more. Local policy: L33631 Outpatient Physical and Occupational Therapy Services. Check a diagnosis for 0552T.
First covered codes: H81.11 Benign paroxysmal vertigo, right ear; H81.12 Benign paroxysmal vertigo, left ear; H81.13 Benign paroxysmal vertigo, bilateral.
Coverage analysis history
CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links one analysis to NCD 160.12, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.
- CAG-00153R Neuromuscular Electrical Stimulation (NMES) for Spinal Cord Injury (1st Recon, Closed)
Revision history
05/2006 - Added cross-reference to section 220. Effective date 10/01/2006. ( TN 55 ) (CR4014)
11/2002 - Provided coverage for walking, and maintained noncoverage for treatment of disuse atrophy in SCI patients. Effective and implementation dates 04/01/2003. ( TN 160 ) (CR 2314)
06/1988 - Added cross-reference to section 45-25. Effective date 04/14/1988. (TN 26)
How this NCD shows up on remittances
A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.
For teams evaluating QuickIntell software
Evaluate a coverage-review workflow around NCD 160.12
Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — NCD 160.12
What does NCD 160.12 cover?
Coverage of NMES to treat muscle atrophy is limited to the treatment of disuse atrophy where nerve supply to the muscle is intact, including brain, spinal cord and peripheral nerves, and other non-neurological reasons for disuse atrophy. Some examples would be casting or splinting of a limb, contracture due to scarring of soft tissue as in burn lesions, and hip replacement surgery (until orthotic training begins). The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.
When did NCD 160.12 take effect?
The current version (2) is effective 10/01/2006, implemented 10/02/2006, published in transmittal 55. CMS lists 2 versions of this NCD.
Does a Local Coverage Determination override NCD 160.12?
No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database NCDs via the CMS Coverage APIVersion API snapshot 2026-09-27 · effective 2026-09-20 · file national-coverage-ncd.jsonSHA-256 a90fadfd264b9ef4…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- Medicare Coverage Database national coverage analyses (NCA/CAL report) via the CMS Coverage APIVersion API snapshot 2026-11-16 · effective 2026-11-16 · file national-coverage-ncacal.jsonSHA-256 563369a07b95140a…
Disclaimer
This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.